Centre approves Corbevax as precaution dose
Follow The Hawk on Google News+ FollowAdvertisement
New Delhi: According to the source, the Corbevax vaccine will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines. Meanwhile, India on Wednesday reported 16,047 new Covid-19 cases in the last 24 hours.
The Centre on Wednesday approved Biological E's Corbevax as a heterologous precaution dose for adults above 18 years for restricted use with two doses of either Covishield or Covaxin, said a source.
Advertisement
According to the source, the Corbevax vaccine will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines.
Also read'Fatty liver-free campaign' in Ranchi from Nov 23, MoS Sanjay Seth to take lead
Meanwhile, India on Wednesday reported 16,047 new Covid-19 cases in the last 24 hours.
In the same period, there were 54 additional deaths, taking the nationwide death toll to 5,26,826.
Get The Hawk first on Google
Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.
Advertisement








